Estimating the future global dose demand for measles-rubella microarray patches

• Main Authors: Melissa Ko (Author), Stefano Malvolti (Author), Thomas Cherian (Author), Carsten Mantel (Author), Robin Biellik (Author), Courtney Jarrahian (Author), Marion Menozzi-Arnaud (Author), Jean-Pierre Amorij (Author), Hans Christiansen (Author), Mark J. Papania (Author), Martin I. Meltzer (Author), Balcha Girma Masresha (Author), Desiree Pastor (Author), David N. Durrheim (Author), Birgitte Giersing (Author), Mateusz Hasso-Agopsowicz (Author)
• Format: Book
• Published: Frontiers Media S.A., 2023-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

BackgroundProgress toward measles and rubella (MR) elimination has stagnated as countries are unable to reach the required 95% vaccine coverage. Microarray patches (MAPs) are anticipated to offer significant programmatic advantages to needle and syringe (N/S) presentation and increase MR vaccination...